Jennifer Wargo

Jennifer Wargo is a world leader in gut microbiome and cancer immunotherapy research, having demonstrated that gut microbiome composition predicts response to PD-1 checkpoint blockade in melanoma patients. Her laboratory studies how specific gut bacteria modulate anti-tumor immunity and how dietary and probiotic interventions can optimize immunotherapy outcomes. She has led clinical trials of fecal microbiota transplantation to sensitize anti-PD-1 resistant melanoma patients, showing proof-of-concept immune reconstitution. She is among the most influential figures in the emerging field of oncology microbiome research.